Answers are grounded in this paper and cite their sources.
The concept of implantable glucose sensors has been promulgated for more than 40 years. It is now accepted that continuous glucose monitoring (CGM) increases quality of life by allowing informed diabetes management decisions as a result of more optimized glucose control. The focus of this article is to provide a brief overview of the CGM market history, emerging technologies, and the foreseeable challenges for the next CGM generations as well as proposing possible solutions in an effort to advance the next generation of implantable sensor.
No takes yet. Share an insight, caveat, or question.
Didyuk et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: